They demonstrated that secretion of GM-CSF from the transduced tumor cells resulted in a vector dose-dependent retardation of tumor growth in the amplicon-injected tumor as well as the contralateral uninjected tumor, and concomitant extension of mouse survival rate. This evidence concerns the gene CSF2 and neoplasm.